指南与共识血栓与止血

美国血液学会2018年静脉血栓栓塞症管理指南:妊娠期静脉血栓栓塞症

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.
指南 / 共识 · Blood Adv · 2018-01-01

美国血液学会组织多学科指南小组,采用GRADE方法制定妊娠期静脉血栓栓塞症(VTE)防治指南,共形成31条推荐,涉及VTE及浅静脉血栓治疗、VTE诊断和血栓预防;强烈推荐急性VTE使用低分子肝素而非普通肝素。

要点

  • 急性VTE强烈推荐低分子肝素而非普通肝素。
  • 多数推荐为条件性推荐,包括急性VTE低分子肝素每日两次或每日一次给药。
  • 有自发性或激素相关VTE史者强烈推荐产前抗凝预防(证据确定性低)。

核心结论

  • 急性VTE强烈推荐低分子肝素而非普通肝素。
  • 多数推荐为条件性推荐,包括急性VTE低分子肝素每日两次或每日一次给药、低危急性VTE初始门诊治疗优于住院,以及反对常规监测抗Xa因子指导低分子肝素剂量。
  • 有自发性或激素相关VTE史者强烈推荐产前抗凝预防(证据确定性低);既往VTE伴已消退的非激素诱发危险因素者条件性推荐反对产前抗凝预防。

研究设计与样本

  • 美国血液学会(ASH)成立多学科指南小组,平衡利益冲突以尽量减少偏倚。
  • 麦克马斯特大学GRADE中心支持指南制定过程,包括更新或执行系统证据评价。
  • 小组根据对临床医生和患者的重要性优先确定临床问题和结局。
  • 采用推荐分级的评估、制定与评价(GRADE)方法评估证据并形成推荐。
  • 指南共形成31条推荐,涉及VTE和浅静脉血栓治疗、VTE诊断和血栓预防。

主要发现

  • 妊娠期VTE约使每1000次分娩中的1.2次复杂化。
  • 尽管绝对风险低,妊娠相关VTE是孕产妇发病和死亡的主要原因之一。
  • 小组就VTE和浅静脉血栓治疗、VTE诊断和血栓预防共达成31条推荐。

关键数值与推荐

  • 急性VTE:强烈推荐低分子肝素而非普通肝素。
  • 急性VTE治疗:条件性推荐低分子肝素每日两次或每日一次给药。
  • 低危急性VTE:条件性推荐初始门诊治疗而非住院。
  • VTE治疗中低分子肝素剂量:条件性推荐反对常规监测抗Xa因子。
  • 有自发性或激素相关VTE史:强烈推荐产前抗凝预防(证据确定性低);既往VTE伴已消退的非激素诱发危险因素:条件性推荐反对产前抗凝预防。

临床怎么用

  • 指南旨在支持患者、临床医生和其他人员在妊娠相关VTE预防和管理中做出决策。
  • 急性VTE治疗强烈推荐低分子肝素而非普通肝素。
  • 急性VTE治疗条件性推荐低分子肝素每日两次或每日一次给药。
  • 低危急性VTE条件性推荐初始门诊治疗而非住院。
  • VTE治疗中低分子肝素剂量条件性推荐反对常规监测抗Xa因子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) complicates ∼1.2 of every 1000 deliveries. Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal morbidity and mortality. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians and others in decisions about the prevention and management of pregnancy-associated VTE. METHODS: ASH formed a multidisciplinary guideline panel balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations. RESULTS: The panel agreed on 31 recommendations related to the treatment of VTE and superficial vein thrombosis, diagnosis of VTE, and thrombosis prophylaxis. CONCLUSIONS: There was a strong recommendation for low-molecular-weight heparin (LWMH) over unfractionated heparin for acute VTE. Most recommendations were conditional, including those for either twice-per-day or once-per-day LMWH dosing for the treatment of acute VTE and initial outpatient therapy over hospital admission with low-risk acute VTE, as well as against routine anti-factor Xa (FXa) monitoring to guide dosing with LMWH for VTE treatment. There was a strong recommendation (low certainty in evidence) for antepartum anticoagulant prophylaxis with a history of unprovoked or hormonally associated VTE and a conditional recommendation against antepartum anticoagulant prophylaxis with prior VTE associated with a resolved nonhormonal provoking risk factor.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018. PMID: 30482767. doi:10.1182/bloodadvances.2018024802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。